GW Pharmaceuticals (GWP)

 

GWP Share PerformanceMore

52 week high0.0000
52 week low0.0000
52 week change 0.0000 (0.00%)
4 week volume0 20/11/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Best AIM companies of 2017

The annual AIM Awards are almost upon us, so former AIM writer of the year Andrew Hore names the small-cap compa...

12 AIM shares in the 1,000% club

With AIM back near 1,000 for the first time in nine years, former AIM writer of the year Andrew Hore analyses the best ...

Cancellation - GW Pharmaceuticals Plc

RNS Number: 8466Q AIM 05 December 2016 NOTICE 05/12/2016 7:00am NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM GW PHARMACEUTICALS PLC At the request of the company trading on AIM for the under-mentioned securities has been cancelled from 05/12/2016 7:00am ORDINARY SHARES OF 0.1P EACH, FULLY PAID (30544...

American Society of Epilepsy Annual Meeting

RNS Number: 7013Q GW Pharmaceuticals PLC 01 December 2016 GW Pharmaceuticals plc Announces Epidiolex (cannabidiol) Data Presentations and Educational Programs at the American Society of Epilepsy Annual Meeting - Presentations include clinical results from Phase 3 programs in Lennox-Gastaut Syndrome and Dravet Syndrome, as well as additional ind...

GW Pharmaceuticals schedules FY results

GW Pharmaceuticals will announce its fourth quarter and year-end financial results for the period ending 30 September o...

Notice of Q4 and year-end results

RNS Number: 4818Q GW Pharmaceuticals PLC 30 November 2016 GW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 5 December, 2016 London, UK, 30 Nov 2016: GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and comm...

Holding(s) in Company

RNS Number: 9985P GW Pharmaceuticals PLC 24 November 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii GW Pharmaceuticals PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting r...

GW chief exec to present Piper Jaffray conference

GW Pharmaceuticals chief executive Justin Gover will present at the 28th annual Piper Jaffray Healthcare Conference at ...

Latest discussion posts More

  • Re: whats going on re shareprice?

    Just looking up to see when i first bought this share and started posting . I knew it must be before October 2012. I note nk 1999 asked if i was on it.... lol. If that is ...
    16-Dec-2017
    Ripley94
  • Re: GW AIM delisting - advice please

    Hi MischasMate, did you find a broker as I am in the same position. Thanks
    22-Dec-2016
    JC74B
  • Re: GW AIM delisting - advice please

    I don't know for sure, but AJ Bell/YouInvest have been very good for me (low commission, helpful when it came to Open Offers for GKP and SXX) and I do know that I can trade ...
    14-Dec-2016
    in4apennyin4amil1

Users' HoldingsMore

Users who hold GW Pharmaceuticals also hold..
India Midcap A Inc GBP100%
ETFS PHYS GLD�100%
Eurpn Alp Inc Z Acc100%
ISF FronMkt Eq C Acc NV £100%
Miton UK Smaller Companies B Acc100%

Codes & Symbols

ISINGB0030544687
SymbolsGWP, LSE:GWP, GWP.L, GWP:LN, LON:GWP, XLON:GWP

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account